midazolam has been researched along with Panic Attacks in 5 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " low-dose intranasal midazolam in five patients diagnosed with DSM-III-R panic disorder." | 9.07 | The use of low-dose intranasal midazolam to treat panic disorder: a pilot study. ( Clary, C; Dever, AI; Mandos, LA; Schweizer, E, 1992) |
| " low-dose intranasal midazolam in five patients diagnosed with DSM-III-R panic disorder." | 5.07 | The use of low-dose intranasal midazolam to treat panic disorder: a pilot study. ( Clary, C; Dever, AI; Mandos, LA; Schweizer, E, 1992) |
| " Combined, chronic administration of these doses yielded a sustained synergism in motor performance impairment, which contrasted with the antagonism usually found between the benzodiazepines and methylxanthines when performance is evaluated by psychomotor tests not requiring fine motor control." | 1.28 | Sustained synergism by chronic caffeine of the motor control deficit produced by midazolam. ( Falk, JL; Lau, CE, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strauss, CV | 1 |
| Vicente, MA | 1 |
| Zangrossi, H | 3 |
| de Paula Soares, V | 1 |
| Bueno, CH | 1 |
| Nogueira, RL | 1 |
| Soares, VP | 1 |
| Viana, MB | 1 |
| Lau, CE | 1 |
| Falk, JL | 1 |
| Schweizer, E | 1 |
| Clary, C | 1 |
| Dever, AI | 1 |
| Mandos, LA | 1 |
1 trial available for midazolam and Panic Attacks
| Article | Year |
|---|---|
The use of low-dose intranasal midazolam to treat panic disorder: a pilot study.
Topics: Administration, Intranasal; Adult; Double-Blind Method; Female; Humans; Male; Midazolam; Panic Disor | 1992 |
4 other studies available for midazolam and Panic Attacks
| Article | Year |
|---|---|
Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Dark Adapta | 2013 |
Stimulation of 5-HT1A or 5-HT2A receptors in the ventrolateral periaqueductal gray causes anxiolytic-, but not panicolytic-like effect in rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety Disorders; Avoidance Learning; Escape Re | 2009 |
Panicolytic-like effect induced by the stimulation of GABAA and GABAB receptors in the dorsal periaqueductal grey of rats.
Topics: Analysis of Variance; Animals; Anxiety Disorders; Avoidance Learning; Baclofen; Behavior, Animal; Ca | 2005 |
Sustained synergism by chronic caffeine of the motor control deficit produced by midazolam.
Topics: Animals; Caffeine; Discrimination Learning; Drug Synergism; Male; Midazolam; Panic Disorder; Psychom | 1991 |